In parallel, synovial sarcoma is defined by the hallmark SS18–SSX fusion oncoprotein, which leads to a rare gain-of-function by mistargeting BAF and activates bivalent genes located at broad polycomb domains [303,304]. The gene discussed is BANF1; the disease is synovial sarcoma.